Edina is leading the validation of a prognostic biomarker for Alzheimer’s disease using an in vitro neurogenesis assay and investigating how changes in gut microbiota composition mediate the neuroinflammation, neuroplasticity changes and cognitive dysfunction in Alzheimer’s disease.
Thuret Lab 